Skip to content

Mannkind MNKD Asset turnover

Asset turnover at other companies

Eli Lilly logo
Eli LillyLLY
0.7×+0.1×
LQD
Liquidia CorporationLQDA
0.9×+0.8×
Tenet Healthcare logo
Tenet HealthcareTHC
0.7×0.0×
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
0.2×+0.2×
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-0.1×
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
+0.1×

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Calculated from Mannkind’s reported figures.

Based on trailing twelve months.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's asset turnover?
Mannkind (MNKD) reported asset turnover of 0.6× in Q1 2026.
How has Mannkind's asset turnover changed year-over-year?
Mannkind's asset turnover decreased by 6.4% year-over-year, from 0.7× to 0.6×.
What is the long-term trend for Mannkind's asset turnover?
Over 5 years (2020 to 2025), Mannkind's asset turnover has grown at a -1.8% compound annual growth rate (CAGR), from 0.6× to 0.6×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.